Jie Li

Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States

G. Chai, Mayura U. Shinde, Nicole R Haug, 2020, Pharmacoepidemiology and drug safety.

EXCELS study results do not rule out potential cancer risk with omalizumab.

P. Starke, M. Goulding, S. Seymour, 2015, The Journal of allergy and clinical immunology.

Trends in oral and vaginally administered estrogen use among US women 50 years of age or older with commercial health insurance

S. R. Slaughter, W. Liu, J. Weissfeld, 2017, Menopause.

Assessing medical product safety during pregnancy using parameterizable tools in the sentinel distributed database

Jennifer G. Lyons, S. Toh, Catherine G Corey, 2022, Pharmacoepidemiology and drug safety.

The Effect of FDA Drug Safety Communications on Patterns of Tiotropium Dispensing: A U.S. Health Plan Claims Database Study

J. Major, Esther H Zhou, S. Seymour, 2018, Journal of managed care & specialty pharmacy.